To this end, we evaluated MRI and PET-derived imaging biomarkers in CALR and CALS HNSCC xenografts to identify and characterize any phenotypic differences in vivo associated with differential sensitivity to EGFR TKIs (33). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.